Toggle light / dark theme

Year 2023 😗😁


Famed musician and former Elon Musk boo Claire “Grimes” Boucher wanted a brain-computer interface (BCI) for her birthday — and one of Neuralink’s apparent competitors was happy to comply.

After Grimes tweeted about getting a “non invasive brain computer interface” for her birthday, AJ Keller, the CEO of the startup Neurosity, confirmed in an interview with Insider that his firm had indeed made a custom brain gadget for the “Kill V. Maim” singer.

While a tech company sending a nerdy sci-fi celebrity fan a gadget wouldn’t really be news on its own, the fact that Grimes is the mother to two of Musk’s children and is seemingly on pretty acrimonious terms with the Canadian-South African billionaire, who owns perhaps the most famous and one of the most controversial BCI companies in the world, makes this story incredibly juicy.

Monitoring levels of DNA shed by tumors and circulating in the bloodstream could help doctors accurately assess how gastroesophageal cancers are responding to treatment, and potentially predict future prognosis, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg–Kimmel Institute for Cancer Immunotherapy.

The owner of Novo Nordisk, the drugmaker that gave the world Ozempic and Wegovy, is funding a new supercomputer powered by Nvidia’s artificial intelligence technology with a key aim of discovering new medicines and treatments.

The Novo Nordisk Foundation has awarded France’s Eviden a contract to build what the computing company says will be one of the world’s most powerful supercomputers, able to process vast amounts of data using AI.

It should provide “unprecedented potential to accelerate groundbreaking scientific discoveries in areas such as drug discovery, disease diagnosis and treatment,” CĂ©dric Bourrasset, Eviden’s head of quantum computing, said in a statement.